One Year On Herceptin For Breast Cancer Ideal
10/01/2012
Patients in early-stage HER2-positive breast cancer should remain on Herceptin (trastuzumab) treatment for one year, and not two years or six months, according to a final analysis of the Phase III HERA trial, pharmaceutical company Roche and the Breast International Group announced today...
Mouse Model Sees Reduction In Deadly Complication Of Stem Cell Transplants
10/01/2012
Studying leukemia in mice, researchers at Washington University School of Medicine in St. Louis have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia returns...
Microbubble technique could serve as another monitoring tool for active surveillance in low-grade cancer patients, say Thomas Jefferson University researchers Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, making it a more appropriate approach for screening clinically important cancers and monitoring low-risk one...
Researchers Find Possible Molecular Key To Regulation Of Ovarian Cancer Stem Cells
10/01/2012
Researchers at Moffitt Cancer Center have discovered that the micro ribonucleic acid miR-214 plays a critical role in regulating ovarian cancer stem cell properties. This knowledge, said the researchers, could pave the way for a therapeutic target for ovarian cancer. The study appears in a recent issue of the The Journal of Biological Chemistry. According to the study's lead author, Jin Q...
Researchers Aim To Eliminate Invasive Cervical Cancer
10/01/2012
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and The Ohio State University have published a paper in the September issue of Cancer Epidemiology, Biomarkers & Prevention that provides an overview on preventing invasive cervical cancer...
Mouse Model Sees Reduction In Deadly Complication Of Stem Cell Transplants
10/01/2012
Studying leukemia in mice, researchers at Washington University School of Medicine in St. Louis have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia returns...
Researchers Find Possible Molecular Key To Regulation Of Ovarian Cancer Stem Cells
10/01/2012
Researchers at Moffitt Cancer Center have discovered that the micro ribonucleic acid miR-214 plays a critical role in regulating ovarian cancer stem cell properties. This knowledge, said the researchers, could pave the way for a therapeutic target for ovarian cancer. The study appears in a recent issue of the The Journal of Biological Chemistry. According to the study's lead author, Jin Q...
Researchers Aim To Eliminate Invasive Cervical Cancer
10/01/2012
Researchers at Moffitt Cancer Center and colleagues at the University of South Florida and The Ohio State University have published a paper in the September issue of Cancer Epidemiology, Biomarkers & Prevention that provides an overview on preventing invasive cervical cancer...
New studies that reveal for the first time the real economic and human costs of caring for cancer patients in Europe will be presented during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna...
Microbubble technique could serve as another monitoring tool for active surveillance in low-grade cancer patients, say Thomas Jefferson University researchers Contrast-enhanced ultrasound was found to better detect high-grade prostate cancer than conventional methods, making it a more appropriate approach for screening clinically important cancers and monitoring low-risk one...